Company intelligence / Profile preview

RyboDyn

San Diego, California, USArybodyn.com ↗

Ownership: Private
Development stage: Preclinical

Overview

RyboDyn has discovered over 8,000 previously unknown protein fragments using its proprietary technology—about a thousand of which are specific to cancer cells. These discoveries enable the development of highly targeted immunotherapies with potential applications across multiple cancer types. The company recently closed a $4 million pre-seed round to advance its drug development efforts and expand partnerships. Independent validation supports the therapeutic potential of their novel targets.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Monoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Peptide-based therapeuticsImmunotherapies
Industry: Biotech

Partnerships

SOSV IndieBio acceleratorcollaborations with Oregon Health & Science University for IP licensingacademic collaborations with Moffitt Cancer Center for independent validationseeking further biopharma partners for pipeline advancement.

Beyond the preview

Go deeper on RyboDyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RyboDyn.

Explore the full profile